Viemed Q2 FY26 net income falls 12.45% to USD 2.76 million; revenue rises 23.9% to USD 78.1 million
PUBT · 1d ago
Share
Listen to the news
- Viemed Healthcare Q2 2026 revenue rose 23.9% year over year to USD 78.1 million, setting a quarterly record.
- Net income attributable to shareholders fell to USD 2.8 million, or USD 0.07 per diluted share.
- Adjusted EBITDA (non-GAAP) slipped 4% to USD 13.7 million, as Q2 2025 included a USD 1 million non-recurring disposal gain.
- Ventilator patients climbed 4% from a year earlier to 12,635; PAP therapy patients more than doubled, rising 44% to 37,825.
- Raised 2026 revenue outlook to USD 314 million-USD 320 million; adjusted EBITDA (non-GAAP) forecast narrowed to USD 64 million-USD 68 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viemed Healthcare Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608031700ACCESSWRNAPR_____1200721) on August 03, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending